Have your say: Biotech Blueprint goals


AusBiotech is preparing for Australia's life science industry’s future, and the sector is invited to have their say on the draft goals that will underpin and drive its decadal strategy: the Biotech Blueprint.

The six draft goals consider what success looks like for the biotech industry in 2030, and what metrics progress should be determined and tracked against. The goals have been developed taking into account the current state of the industry and future opportunities, global megatrends, and feedback from AusBiotech + Invest 2020’s panel session, and from a number of key opinion leaders.

AusBiotech welcomes feedback on the specific opportunities identified, as well as any others that should be highlighted, and is important as AusBiotech sets the foundations of a clear and ambitious plan for the future of our industry.

2020 has been a pivotal year in many ways, and so now is the time to be ambitious about how the biotechnology industry cannot just help solve problems, but also generate the long-term economic growth and social capital that will be needed as we emerge from the current pandemic.

COVID-19 is a reminder that Australia will need its biotech industry to help it face uncertain future threats. It is, therefore, a good time to contemplate what a vibrant and valuable Australian biotechnology industry could look like another decade from now, and identify the steps that should be taken in the near term to ensure that positive future is realised.

AusBiotech is focused on the delivery of members’ and industry’s needs and is committed to growing the industry. The Biotech Blueprint is a powerful long-term approach to healthcare and will ensure that the pipeline of innovative technologies being developed and manufactured in Australia continues to bring crucial life-enhancing and enriching benefits directly to patients.

The survey should take up to 10 minutes to complete, and closes 30 November 2020.

Take the survey now.